Clincosm LogoSign in Get a demo

pediatric cancer

Showing NaN - NaN of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory Cancer, Refractory Tumor, Cancer Pediatric Trial in United States (9-ING-41, Irinotecan, Temozolomide)

Recruiting
  • Refractory Cancer
  • +10 more
  • Aurora, Colorado
  • +7 more
Dec 31, 2022

Genetic Overlap Between Anomalies and Cancer in Kids in

Recruiting
  • Congenital Anomaly
  • Pediatric Cancer
  • Whole Genome Sequencing
  • +3 more
  • Houston, Texas
    Baylor College of Medicine/ Dan L Duncan Comprehensive Cancer Ce
Dec 9, 2022

Pediatric Cancer Trial in Los Angeles, Wilmington, Houston (eSCCIP/eSCCIP-SP, Coping Space)

Not yet recruiting
  • Pediatric Cancer
  • eSCCIP/eSCCIP-SP
  • Coping Space
  • Los Angeles, California
  • +2 more
Nov 22, 2022

Pediatric Cancer Trial in Canada, United States (Registry)

Recruiting
  • Pediatric Cancer
  • Registry
  • Atlanta, Georgia
  • +6 more
Aug 23, 2022

Pediatric Cancer, Quality of Life Trial in Canada, United States (SPARK Symptom Screening Linked to Feedback to Providers)

Recruiting
  • Pediatric Cancer
  • Quality of Life
  • SPARK Symptom Screening Linked to Feedback to Providers
  • Phoenix, Arizona
  • +20 more
Jun 15, 2022

Barriers and Facilitators in Access to OT/PT in Pediatric Cancer

Recruiting
  • Pediatric Cancer
  • Patient population
  • Houston, Texas
    M D Anderson Cancer Center
Mar 23, 2022

Leukemia, Pediatric Cancer Trial in Houston (Epratuzumab, Fludarabine, Cyclophosphamide)

Terminated
Has Results
  • Leukemia
  • Pediatric Cancer
  • Houston, Texas
    UT MD Anderson Cancer Center
May 19, 2014